Prognosis of Lung Cancer Patients Admitted to the Medical Intensive Care Unit
의약학 > 내과학
황기은 , 김학렬 , 정은택
대한결핵 및 호흡기학회
대한결핵및호흡기학회 추계학술발표초록집 2012년, 제114권 183(총1페이지)
0y909874.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    30원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    Introduction: Lung cancer remains the leading cause of cancer mortality worldwide. Despite lung cancer`s poor prognosis, lung cancer patients are increasingly admitted to medical intensive care unit (MICU) for critical illness. The aim of the this study was to assess the outcome of lung cancer patients who admitted to a MICU and to identify the measurable predictors of their MICU outcome. Methods: We retrospectively evaluated MICU outcomes and identified risk factors for MICU mortality in consecutive patients with lung cancer admitted to the MICU between 2007 and 2012. A total of 105 lung cancer patients were included during the study period. The mean age±SD at MICU admission was 71.2±8.6 yrs (85% males, 15% females). Of 105 included patients, 78 had non-small cell lung cancer. Extensive disease (NSCLC stage III, IV, disseminated small cell lung cancer) was diagnosed in 98 patients (93%). The MICU mortality was 62% (64 patients). The main reasons for MICU admission were acute respiratory failure (60%). Results: The independent predictors of poor MICU outcome were: diabetes mellitus on past history (p=0.025); Acute Physiology And Chronic Health Evaluation III (p=0.012); the need for mechanical ventilation (p=0.012); the use of vasopressor (p=0.000); complication of ARF (p=0.003), presence of multiorgan failure (p=0.000). Conclusions: We found that MICU mortality was not influenced by the type and stage of lung cancer but increased with the severity of the organ failure at MICU admission.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일
    copyright (c) 2009 happynlife. steel All reserved.